Hyperplasia of mammary glands (phlegm and blood stasis syndrome)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. accord with the diagnostic criteria of hyperplasia of mammary glands; 2. conform to the standard of TCM syndrome differentiation of phlegm and blood stasis syndrome; 3. ultrasound nodule size greater than 0.3cm and less than 1cm or ultrasound cystic nodules larger than 0.3cm and less than 1.5cm; 4. During the 4 cleaning period, the pain score of VAS any more than 4 cent; 5. The 5 BI-RADS classification of breast nodules less than 3 level and consideration of nodular hyperplasia; 6. between the ages of 18 to 55 years of age (including the age of 18 and between women), there are basic rules of the menstrual cycle and menstrual period of the woman; 7. subjects were informed consent, voluntary trial and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. patients with breast cancer, inflammatory disease and other endocrine diseases; 2. menstrual cycles or periods of severe irregularity (menstrual cycles > 35 days and days and / or periods of "less than 3 days or" 7 days "). 3. liver function, renal function of a super normal value of the upper limit; 4. during the trial, the use of contraceptive drugs and the use of hormone drugs within three months before screening; 5. before the screening of a month to take the treatment of the disease of Chinese and Western medicine; 6. combined with cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic system and other serious primary diseases, or psychiatric patients; 7. prepare for pregnancy, pregnancy, lactation and menopausal women; 8. allergic to or known to be allergic to the drug or component; 9. alcohol abuse and other drug abuse history (alcoholism standards: men drink more than 50 grams of alcohol per day, women drink more than 30 grams of alcohol per day; drug abuse through clinical symptoms to determine; 10. to participate in other clinical trials in the past 1 months; 11. the researchers found it inappropriate to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Breast size changes; | — |
Countries
China
Contacts
Beijing Hospital of Traditional Chinese Medicine